1. Home
  2. IMNM vs CLNE Comparison

IMNM vs CLNE Comparison

Compare IMNM & CLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • CLNE
  • Stock Information
  • Founded
  • IMNM 2006
  • CLNE 2001
  • Country
  • IMNM United States
  • CLNE United States
  • Employees
  • IMNM N/A
  • CLNE N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • CLNE Natural Gas Distribution
  • Sector
  • IMNM Health Care
  • CLNE Utilities
  • Exchange
  • IMNM Nasdaq
  • CLNE Nasdaq
  • Market Cap
  • IMNM 585.5M
  • CLNE 610.0M
  • IPO Year
  • IMNM 2020
  • CLNE 2007
  • Fundamental
  • Price
  • IMNM $11.08
  • CLNE $3.44
  • Analyst Decision
  • IMNM Strong Buy
  • CLNE Strong Buy
  • Analyst Count
  • IMNM 5
  • CLNE 3
  • Target Price
  • IMNM $28.60
  • CLNE $5.00
  • AVG Volume (30 Days)
  • IMNM 1.0M
  • CLNE 2.6M
  • Earning Date
  • IMNM 03-27-2025
  • CLNE 02-24-2025
  • Dividend Yield
  • IMNM N/A
  • CLNE N/A
  • EPS Growth
  • IMNM N/A
  • CLNE N/A
  • EPS
  • IMNM N/A
  • CLNE N/A
  • Revenue
  • IMNM $10,129,000.00
  • CLNE $413,396,000.00
  • Revenue This Year
  • IMNM N/A
  • CLNE N/A
  • Revenue Next Year
  • IMNM N/A
  • CLNE $2.19
  • P/E Ratio
  • IMNM N/A
  • CLNE N/A
  • Revenue Growth
  • IMNM N/A
  • CLNE N/A
  • 52 Week Low
  • IMNM $8.97
  • CLNE $2.17
  • 52 Week High
  • IMNM $30.96
  • CLNE $3.49
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 54.91
  • CLNE 55.95
  • Support Level
  • IMNM $10.29
  • CLNE $3.03
  • Resistance Level
  • IMNM $11.43
  • CLNE $3.47
  • Average True Range (ATR)
  • IMNM 0.77
  • CLNE 0.15
  • MACD
  • IMNM 0.18
  • CLNE 0.03
  • Stochastic Oscillator
  • IMNM 85.23
  • CLNE 52.56

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas, and renewable natural gas as an alternative fuel for vehicles. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.

Share on Social Networks: